Experiment: 2LUE

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.6 mM [U-98% 13C; U-98% 15N] entity_1-1, 4.9 mM entity_2-2, 70 mM sodium phosphate-3, 30 mM sodium chloride-4, 0.3 mM DSS-5, 5 mM Protease inhibitors cocktail-6	95% H2O/5% D2O	0.05	6.8	ambient	288
2	2D 1H-13C HSQC	0.6 mM [U-98% 13C; U-98% 15N] entity_1-1, 4.9 mM entity_2-2, 70 mM sodium phosphate-3, 30 mM sodium chloride-4, 0.3 mM DSS-5, 5 mM Protease inhibitors cocktail-6	95% H2O/5% D2O	0.05	6.8	ambient	288
3	2D 1H-13C HSQC aromatic	0.6 mM [U-98% 13C; U-98% 15N] entity_1-1, 4.9 mM entity_2-2, 70 mM sodium phosphate-3, 30 mM sodium chloride-4, 0.3 mM DSS-5, 5 mM Protease inhibitors cocktail-6	95% H2O/5% D2O	0.05	6.8	ambient	288
4	3D HNCACB	0.6 mM [U-98% 13C; U-98% 15N] entity_1-1, 4.9 mM entity_2-2, 70 mM sodium phosphate-3, 30 mM sodium chloride-4, 0.3 mM DSS-5, 5 mM Protease inhibitors cocktail-6	95% H2O/5% D2O	0.05	6.8	ambient	288
5	3D HNCO	0.6 mM [U-98% 13C; U-98% 15N] entity_1-1, 4.9 mM entity_2-2, 70 mM sodium phosphate-3, 30 mM sodium chloride-4, 0.3 mM DSS-5, 5 mM Protease inhibitors cocktail-6	95% H2O/5% D2O	0.05	6.8	ambient	288
6	3D HCCH-TOCSY	0.6 mM [U-98% 13C; U-98% 15N] entity_1-1, 4.9 mM entity_2-2, 70 mM sodium phosphate-3, 30 mM sodium chloride-4, 0.3 mM DSS-5, 5 mM Protease inhibitors cocktail-6	95% H2O/5% D2O	0.05	6.8	ambient	288
7	3D 1H-15N NOESY	0.6 mM [U-98% 13C; U-98% 15N] entity_1-1, 4.9 mM entity_2-2, 70 mM sodium phosphate-3, 30 mM sodium chloride-4, 0.3 mM DSS-5, 5 mM Protease inhibitors cocktail-6	95% H2O/5% D2O	0.05	6.8	ambient	288
8	3D 1H-13C NOESY aliphatic	0.6 mM [U-98% 13C; U-98% 15N] entity_1-1, 4.9 mM entity_2-2, 70 mM sodium phosphate-3, 30 mM sodium chloride-4, 0.3 mM DSS-5, 5 mM Protease inhibitors cocktail-6	95% H2O/5% D2O	0.05	6.8	ambient	288
9	3D 1H-13C NOESY aromatic	0.6 mM [U-98% 13C; U-98% 15N] entity_1-1, 4.9 mM entity_2-2, 70 mM sodium phosphate-3, 30 mM sodium chloride-4, 0.3 mM DSS-5, 5 mM Protease inhibitors cocktail-6	95% H2O/5% D2O	0.05	6.8	ambient	288
10	3D NOESY-[13C,1H]-HSQC 13C/15N filtered in F1	0.6 mM [U-98% 13C; U-98% 15N] entity_1-1, 4.9 mM entity_2-2, 70 mM sodium phosphate-3, 30 mM sodium chloride-4, 0.3 mM DSS-5, 5 mM Protease inhibitors cocktail-6	95% H2O/5% D2O	0.05	6.8	ambient	288
11	2D 1H-1H NOESY F1,F2 13C/15N filtered	2.5 mM [U-98% 13C; U-98% 15N] entity_1-7, 0.4 mM entity_2-8, 70 mM sodium phosphate-9, 30 mM sodium chloride-10, 0.3 mM DSS-11, 5 mM Protease inhibitors cocktail-12	95% H2O/5% D2O	0.05	6.8	ambient	288
12	3D NOESY-[15N,1H]-FHSQC	0.6 mM [U-98% 13C; U-98% 15N] entity_1-1, 4.9 mM entity_2-2, 70 mM sodium phosphate-3, 30 mM sodium chloride-4, 0.3 mM DSS-5, 5 mM Protease inhibitors cocktail-6	95% H2O/5% D2O	0.05	6.8	ambient	288

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	900
2	Bruker	AVANCE	800
3	Bruker	AVANCE	700
4	Bruker	AVANCE	600
5	Bruker	AVANCE	500

NMR Refinement
Method	Details	Software
restrained energy refinement		TopSpin

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin	2	Bruker Biospin
2	chemical shift calculation	TopSpin	2	Bruker Biospin
3	processing	TopSpin	2	Bruker Biospin
4	data analysis	Sparky	3.114	Goddard
5	chemical shift assignment	Sparky	3.114	Goddard
6	peak picking	Sparky	3.114	Goddard
7	structure solution	CYANA	2	Guntert, Mumenthaler and Wuthrich
8	refinement	OPALp		Koradi, Billeter and Guntert

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.